ClinicalTrials.govpublic full text
Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease
hepatitis c virus, recombinant interferon, tolerated, effective, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 843227
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.